WAG! GROUP CO (PET)

US93042P1093 - Common Stock

0.22  +0.02 (+8.7%)

After market: 0.2166 0 (-1.55%)

Fundamental Rating

2

Taking everything into account, PET scores 2 out of 10 in our fundamental rating. PET was compared to 69 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of PET have multiple concerns. PET is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year PET has reported negative net income.
PET had a negative operating cash flow in the past year.

1.2 Ratios

The Return On Assets of PET (-49.76%) is worse than 87.88% of its industry peers.
Looking at the Return On Equity, with a value of -682.91%, PET is doing worse than 87.88% of the companies in the same industry.
Industry RankSector Rank
ROA -49.76%
ROE -682.91%
ROIC N/A
ROA(3y)-34.31%
ROA(5y)N/A
ROE(3y)-399.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 91.73%, PET belongs to the best of the industry, outperforming 98.48% of the companies in the same industry.
PET does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

PET does not have a ROIC to compare to the WACC, probably because it is not profitable.
PET has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, PET has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -6.23, we must say that PET is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.23, PET is doing worse than 84.85% of the companies in the same industry.
There is no outstanding debt for PET. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.23
ROIC/WACCN/A
WACC14.93%

2.3 Liquidity

PET has a Current Ratio of 0.62. This is a bad value and indicates that PET is not financially healthy enough and could expect problems in meeting its short term obligations.
PET has a Current ratio of 0.62. This is in the lower half of the industry: PET underperforms 78.79% of its industry peers.
A Quick Ratio of 0.62 indicates that PET may have some problems paying its short term obligations.
The Quick ratio of PET (0.62) is worse than 75.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.62

3

3. Growth

3.1 Past

PET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -84.21%.
PET shows a decrease in Revenue. In the last year, the revenue decreased by -3.20%.
EPS 1Y (TTM)-84.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-3.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.43%

3.2 Future

The Earnings Per Share is expected to grow by 29.53% on average over the next years. This is a very strong growth
PET is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.63% yearly.
EPS Next Y22.09%
EPS Next 2Y24.03%
EPS Next 3Y29.53%
EPS Next 5YN/A
Revenue Next Year-8.92%
Revenue Next 2Y0.17%
Revenue Next 3Y26.34%
Revenue Next 5Y24.63%

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PET. In the last year negative earnings were reported.
Also next year PET is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PET's earnings are expected to grow with 29.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.03%
EPS Next 3Y29.53%

0

5. Dividend

5.1 Amount

No dividends for PET!.
Industry RankSector Rank
Dividend Yield N/A

WAG! GROUP CO

NASDAQ:PET (12/20/2024, 8:00:00 PM)

After market: 0.2166 0 (-1.55%)

0.22

+0.02 (+8.7%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)02-10 2025-02-10/amc
Inst Owners56.6%
Inst Owner Change11.25%
Ins Owners12.51%
Ins Owner Change-5.75%
Market Cap10.95M
Analysts46.67
Price Target0.51 (131.82%)
Short Float %7.8%
Short Ratio1.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-89.77%
Min EPS beat(2)-197.03%
Max EPS beat(2)17.49%
EPS beat(4)2
Avg EPS beat(4)-47.54%
Min EPS beat(4)-197.03%
Max EPS beat(4)21.37%
EPS beat(8)4
Avg EPS beat(8)-8.29%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-27.07%
Min Revenue beat(2)-37.45%
Max Revenue beat(2)-16.7%
Revenue beat(4)2
Avg Revenue beat(4)-11.8%
Min Revenue beat(4)-37.45%
Max Revenue beat(4)3.54%
Revenue beat(8)6
Avg Revenue beat(8)0.83%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-62.5%
PT rev (3m)-85.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-28.57%
EPS NY rev (3m)-28.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.11%
Revenue NY rev (1m)-16.63%
Revenue NY rev (3m)-16.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 4.61
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS1.54
BVpS0.05
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49.76%
ROE -682.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.73%
FCFM N/A
ROA(3y)-34.31%
ROA(5y)N/A
ROE(3y)-399.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.68%
Cap/Sales 2.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.62
Altman-Z -6.23
F-Score4
WACC14.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y22.09%
EPS Next 2Y24.03%
EPS Next 3Y29.53%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.43%
Revenue Next Year-8.92%
Revenue Next 2Y0.17%
Revenue Next 3Y26.34%
Revenue Next 5Y24.63%
EBIT growth 1Y-32.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year185.11%
EBIT Next 3Y67.17%
EBIT Next 5Y60.71%
FCF growth 1Y-129.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.84%
OCF growth 3YN/A
OCF growth 5YN/A